Jun Gong, MD Associate Professor of Medicine Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center Jun Gong, MD, is an Associate Professor of Medicine in the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center. His primary clinical interests as a practicing medical oncologist are in gastrointestinal (GI), hepatobiliary, and genitourinary (GU) cancers with a multidisciplinary focus of care along with colleagues from surgery, gastroenterology, radiation oncology, radiology, and urology. Dr. Gong is focused on translational and clinical cancer research with interests in cancer disparities, early therapeutic trials (immunotherapy, targeted therapies, biologics, and other systemic therapies) and biomarker development to improve patient outcomes in GI and GU cancers. More from Jun Videos & Webinars A Nationwide VA Study on Systemic Treatment Patterns in Black Patients with Metastatic Castration-Resistant Prostate Cancer In this session with Dr. Jun Gong, he discusses his study being conducted across the country in VA hospitals about how Black patients with advanced prostate cancer are receiving treatment.
Jun Gong, MD, is an Associate Professor of Medicine in the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center. His primary clinical interests as a practicing medical oncologist are in gastrointestinal (GI), hepatobiliary, and genitourinary (GU) cancers with a multidisciplinary focus of care along with colleagues from surgery, gastroenterology, radiation oncology, radiology, and urology. Dr. Gong is focused on translational and clinical cancer research with interests in cancer disparities, early therapeutic trials (immunotherapy, targeted therapies, biologics, and other systemic therapies) and biomarker development to improve patient outcomes in GI and GU cancers.
More from Jun Videos & Webinars A Nationwide VA Study on Systemic Treatment Patterns in Black Patients with Metastatic Castration-Resistant Prostate Cancer In this session with Dr. Jun Gong, he discusses his study being conducted across the country in VA hospitals about how Black patients with advanced prostate cancer are receiving treatment.
